Engineering Recombinant Chimeric Proteins That Deliver Therapies to the Brain
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c02731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Xuejian Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of High Performance Polymer Materials & Technology, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 2100…. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Protein Engineering, Doxorubicin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Basic Research Program of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of High Performance Polymer Materials & Technology, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.
ORCID-Profile: Xiqun Jiang
Förderung
- Natural Science Foundation of Jiangsu Province
- Basic Research Program of Jiangsu Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Li, C., Chen, W., & Jiang, X. (2025). Engineering Recombinant Chimeric Proteins That Deliver Therapies to the Brain. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c02731
Vancouver
Zhang X, Li C, Chen W, Jiang X. Engineering Recombinant Chimeric Proteins That Deliver Therapies to the Brain. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c02731
BibTeX
@article{Zhang2025,
author = {Zhang, Xuejian and Li, Cheng and Chen, Weizhi and Jiang, Xiqun},
title = {Engineering Recombinant Chimeric Proteins That Deliver Therapies to the Brain},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c02731}
}
EUVIMED